2 studies found for:    12037148 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown 
Has Results
Anti-CD3 mAb Treatment of Recent Onset Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: mAb hOKT3gamma1(Ala-Ala), Teplizumab;   Drug: Placebo Arm
2 Completed
Has Results
Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Anti-CD3 mAb;   Other: Diabetes Standard of Care Treatment;   Dietary Supplement: Iron supplementation

Indicates status has not been verified in more than two years